Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLCby 06/03/2024PR Newswire
AIA Carnival Celebrates Grand Finale after returning to the Central Harbourfront for the first time in four yearsby 06/03/2024PR Newswire
Microsoft launches new initiatives to skill and scale AI transformation in Singaporeby 06/03/2024PR Newswire
Infosys and ATP Renew Partnership until 2026, to Drive AI-first Innovations in Professional Tennisby 06/03/2024PR Newswire
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenyaby 06/03/2024PR Newswire
COMPUTEX 2024 Unveils AI Powerhouses 1,500 Global Exhibitors Converge, Online Registration for Visitors Open Nowby 06/03/2024PR Newswire
